Analgesic Agent

PreclinicalSmall molecule

AAlliance for Clinical Trials in Oncology

Analgesic Agent is one of 10 small molecule programs targeting Renal Pelvis and Ureter Urothelial Carcinoma. It is currently in Preclinical.

Indications

Total Trials

Active Trials

Competitors

Pipeline

Status by Indication[3][1]

Indication

Renal Pelvis and Ureter Urothelial CarcinomaRecruiting

Renal Pelvis and Ureter Urothelial CarcinomaPreclinical

Recruiting

Competition

Competitive Landscape

10 competitors in Renal Pelvis and Ureter Urothelial Carcinoma

#DrugCompanyPhaseTrials

Padcev

Pfizer

Phase 2

1 2

Keytruda

Merck & Co.

Phase 2

1 3

Adriamycin

Pfizer

Preclinical

1 4

Imfinzi

AstraZeneca

Preclinical

1 5

Gemzar

Johnson & Johnson

Preclinical

1 6

Trexall

Jazz Pharmaceuticals

Preclinical

1 7

Neulasta

Amgen

Preclinical

1 8

Platinol

MMcNeil Consumer & Specialty Pharmaceuticals, a Division of McNeil-PPC, Inc.

Preclinical

1 9

Velban

EEastern Cooperative Oncology Group

Preclinical

1 10

Analgesic Agent

AAlliance for Clinical Trials in Oncology

Preclinical

Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.

Timeline

Expected Milestones

Q4 2027

PreclinicalRecruiting

Renal Pelvis and Ureter Urothelial Carcinoma

NCT07630155

Q2 2031

Phase 3Recruiting

Head and Neck Squamous Cell Carcinoma

NCT06992427

Clinical

Trials by Indication[1]

Head and Neck Squamous Cell Carcinoma1 trial

High-Dose Prophylactic Gabapentin (HOPE) to Prevent Opioid Use for Oral Mucositis Pain During Head and Neck Chemoradiotherapy: A Phase III Clinical Trial

Recruiting·AAlliance for Clinical Trials in Oncology·Phase 3·NCT06992427·228 enrolled

Renal Pelvis and Ureter Urothelial Carcinoma1 trial

A Prospective Clinical Assessment of Office-Based Ureteroscopy for Upper Tract Urothelial Carcinoma Utilizing a 6.3 French Single Use Digital Flexible Ureteroscope

Recruiting·UUniversity of Michigan Rogel Cancer Center·Preclinical·NCT07630155·10 enrolled

Sources

References

[1]
ClinicalTrials.gov — 2 trial records for Analgesic Agent. U.S. National Library of Medicine, National Institutes of Health.
[2]
ChEMBL — Analgesic Agent compound record. European Bioinformatics Institute (EMBL-EBI).
[3]
Open Targets Platform — Drug–disease associations for Analgesic Agent. EMBL-EBI & Wellcome Sanger Institute.
[4]
SEC EDGAR — Alliance for Clinical Trials in Oncology company filings. U.S. Securities and Exchange Commission.

Details

Drug Info

Quick Facts

Modality: Small molecule[2]
Highest Phase: Preclinical[1]
Company: AAlliance for Clinical Trials in Oncology

Analgesic Agent

Status by Indication[3][1]

Competitive Landscape

Expected Milestones

Q4 2027

Q2 2031

Trials by Indication[1]

Head and Neck Squamous Cell Carcinoma1 trial

Renal Pelvis and Ureter Urothelial Carcinoma1 trial

References

Drug Info

Quick Facts

Related News